Treatment with tunicamycin alone significantly inhibited PD‐L1 expression in tumor cells, and this inhibitory effect was independent of YY1 expression levels, indicating that glycosylation indeed enhanced the stability of PD‐L1. Here, YY1 is linked to neoplasm.